GLG News by Neurologists

30,000 people over age 18 surveyed Researchers estimated that 61 million Americans are at high risk for vision loss and, of these just more than 50% visited an eye doctor or had a dilated eye exam in the past year. African Americans and Hispanic persons were significantly less likely to visit an...

Global rates of TB infection appear to be leveling. AIDS associated and drug resistant forms of TB may be on the rise.

Keppra has received FDA approval for adjunctive therapy in the treatment of primary generalized tonic-clonic (PGTC) seizures in adults and children 6 years of age and older with idiopathic generalized epilepsy (IGE). This is Keppra’s third approved indication.

The Impliant TOPS-on-Fusion (TM) device has received CE Mark approval.The system allows the surgeon to avoid fusing 2 levels.

Bacterial meningitis is a life threating condition, which must be distinguished from the less serious viral meningitis.  The Xpert EV test has been approved by the FDA.

The article reports on a new FDA warning pertaining to prescription sleep medications.Medications to promote sleep are widely prescribed.New FDA warning could impact prescribing practices

FDA is evaluating Frova for  a new indicationThis could lead to more prescriptions for all triptansThis could improve Frova's market share

The article discusses the problem of pain medication abuse and briefly mentions several treatments under research.

This article raises an important issue which is not widely known by the general public or even among physicians.

This article describes an interesting study which may show that commonly prescribed medications (statins) have an added benefit.